Jingyi Cheng

Title: **Jingyi Cheng: Pioneering Artificial Intelligence in Ophthalmic Disease Diagnosis**

Introduction

Jingyi Cheng is an innovative inventor based in Shanghai, China, known for his significant contribution to the field of ophthalmology through the application of artificial intelligence. With a keen focus on advancing medical technology, Cheng has successfully secured a patent that exemplifies his expertise and dedication.

Latest Patents

Cheng holds a patent for a groundbreaking modeling method and apparatus designed for diagnosing ophthalmic diseases using artificial intelligence. The innovative method involves establishing a comprehensive data collection that includes both ophthalmic images and non-image ophthalmic disease diagnosis questionnaires. By training a first neural network model with the image data and a second classification model with the questionnaire data, Cheng merges these models to create a target classification network model. This model outputs a test result that serves as a diagnosis for various ophthalmic diseases, showcasing how technology can enhance medical diagnostics.

Career Highlights

Throughout his career, Cheng has worked with prestigious organizations, including BGI Shenzhen and the Eye, Ear, Nose, and Throat Hospital of Fudan University. His experience in these institutions has played a pivotal role in shaping his innovative approaches to solving complex medical challenges. Cheng's work not only demonstrates his technical prowess but also his commitment to improving patient outcomes through innovative solutions.

Collaborations

Jingyi Cheng has collaborated with talented colleagues, such as Xiaoqing Liu and Jiaxu Hong. These partnerships have fostered a rich environment for innovation, allowing for the exchange of ideas and expertise that have propelled Cheng's research and inventions forward.

Conclusion

Jingyi Cheng's contributions to ophthalmic disease diagnosis through artificial intelligence mark a significant advancement in medical technology. His pioneering patent reflects a commitment to innovation that has the potential to transform healthcare practices. As he continues to develop new methodologies, Cheng remains a key figure in the intersection of technology and medicine.